The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Treatment of Patient With Major Depressive Disorder
Clinical trial NCT04984512 · RECRUITING
Trial details
- NCT number
- NCT04984512
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-14
- Primary completion
- 2027-07-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.